HIGHLIGHTS
- who: Marco Nassisi from the Maggiore Policlinico, Milan, Italy Department of Clinical Sciences and Community Health, University have published the article: Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration, in the Journal: (JOURNAL)
- what: The authors evaluated the visual impact of the discontinuity of the IVIs treatment in nAMD patients after 6-months of follow-up. In the NA-group, IVI skipping was considered the main reason for the BCVA decrease. The results of this study demonstrate the importance of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.